subject: CHEBI:3901

subject_name: Tetracosactide

object_name: adrenal cortex disorder


subject: CHEBI:3901

object_name: infant morbidity

tested_intervention: yes


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: angiolipoma

tested_intervention: unsure


subject: UMLS:C0962969

subject_name: RAD 001


subject: UMLS:C5401619

object_name: immunodeficiency disease


subject: UMLS:C0939797

subject_name: banana extract

object_name: type 1 diabetes mellitus


subject: DRUGBANK:DB10505

subject_name: Banana


subject: UNII:7K5O7P6QIU

subject_name: LONCASTUXIMAB

object_name: follicular lymphoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: diffuse large B-cell lymphoma


subject: UNII:28X28X9OKV

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:28X28X9OKV

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:28X28X9OKV

object_name: mantle cell lymphoma


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:45783

subject_name: Imatinib

object_name: choroidal neovascularization


subject: CHEBI:45783

object_name: choroidal neovascularization (physical finding)


subject: CHEBI:11909

subject_name: Sepranolone

object_name: traumatic encephalopathy


subject: CHEBI:50169

subject_name: Brexanolone


subject: PUBCHEM.COMPOUND:3367

object_name: transplantation infection


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:681569

subject_name: Clofarabine


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: UMLS:C5198301

object_name: rheumatoid arthritis


subject: CHEBI:6933

subject_name: Midodrine

object_name: pure autonomic failure


subject: CHEBI:6933

object_name: Parkinson disease


subject: CHEBI:6933

object_name: multiple system atrophy


subject: GTOPDB:13629

subject_name: bevasiranib

object_name: macular degeneration


subject: GTOPDB:13629

object_name: age-related macular degeneration


subject: GTOPDB:13629

object_name: retinitis pigmentosa 30


subject: UNII:DGN36694W4

subject_name: Bevasiranib


subject: UNII:DGN36694W4


subject: UNII:DGN36694W4


subject: CHEBI:59163

subject_name: biomarker

object_name: no feeling or sensation of skin


subject: CHEBI:59163

object_name: Sensory Loss


subject: CHEBI:59163

object_name: Post-Operative Pain


subject: CHEBI:59163

object_name: Nociceptive Pain


subject: UNII:T0N62K2M2Y

object_name: B-cell neoplasm


subject: CHEBI:4653

subject_name: Dipyridamole

object_name: hypophosphatemia


subject: CHEBI:4653

object_name: Hypophosphatemia, CTCAE


subject: GTOPDB:12790

subject_name: crovalimab

object_name: autoimmune polyendocrinopathy


subject: GTOPDB:12790

object_name: antiphospholipid syndrome


subject: UNII:H9KH1GP3UU

subject_name: CROVALIMAB


subject: UNII:H9KH1GP3UU


subject: UMLS:C5418336


subject: UMLS:C5418336


subject: CHEBI:188804

subject_name: Telapristone acetate

object_name: uterine fibroid


subject: PUBCHEM.COMPOUND:2863

object_name: Osteoarthritis of glenohumeral joint


subject: CHEBI:16962

subject_name: Cortisone


subject: HMDB:HMDB0001960

subject_name: Tin

object_name: fetal growth restriction


subject: HMDB:HMDB0001960

object_name: Fetal Growth Retardation, CTCAE


subject: CHEBI:30476


subject: CHEBI:30476


subject: UMLS:C0591649

subject_name: Innohep


subject: UMLS:C0591649


subject: UNII:7UQ7X4Y489

subject_name: TINZAPARIN


subject: UNII:7UQ7X4Y489


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: type 2 diabetes mellitus


subject: UMLS:C3540708

object_name: Diabetes


subject: UMLS:C3540708

object_name: diabetes mellitus


subject: UMLS:C3540708

object_name: Foot Ulcer


subject: UMLS:C3540708

object_name: infectious disease


subject: UMLS:C3540708

object_name: Adverse Event Associated with Infection


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:70839

object_name: Recurrent ovarian cancer


subject: CHEBI:70839

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:70839

object_name: ovarian clear cell cystadenocarcinoma


subject: CHEBI:70839

object_name: Recurrent Uterine Corpus Cancer


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: UMLS:C5854507

subject_name: pan-RAF Inhibitor TR128

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Arm Injuries


subject: CHEBI:60789

object_name: pain agnosia


subject: CHEBI:60789

object_name: Pain insensitivity


subject: CHEBI:60789

object_name: Acute Pain


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:60802

subject_name: ropivacaine


subject: PUBCHEM.COMPOUND:164888948

subject_name: Clopidogrel Napadisilate

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:164888948

object_name: coronary atherosclerosis


subject: UNII:MP4UYS4N4U

subject_name: CLOPIDOGREL NAPADISILATE


subject: UNII:MP4UYS4N4U


subject: CHEBI:50693

subject_name: Milrinone

object_name: Persistent Pulmonary Hypertension of the Newborn, AE


subject: CHEBI:176724

subject_name: Etiracetam

object_name: post-traumatic epilepsy


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: PUBCHEM.COMPOUND:1201

subject_name: CALANOLIDE A

object_name: HIV infection


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Neck Carcinoma


subject: CHEBI:50733

object_name: head and neck neoplasm


subject: CHEBI:50733

object_name: head and neck cancer


subject: CHEBI:5847

subject_name: Raltitrexed

object_name: head and neck squamous cell carcinoma


subject: CHEBI:32139

object_name: epilepsy


subject: CHEBI:32139

object_name: renal tubular acidosis


subject: PUBCHEM.COMPOUND:54726193

object_name: bacterial infectious disease


subject: UNII:Y6IUM7395Q


subject: CHEBI:3374

subject_name: Capsaicin

object_name: alopecia areata


subject: CHEBI:3374

object_name: alopecia


subject: UNII:K7G81N94DT

subject_name: Osanetant

object_name: prostate adenocarcinoma


subject: DRUGBANK:DB06544

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: Tinnitus


subject: UMLS:C0678449

object_name: Tinnitus, CTCAE 5.0


subject: UMLS:C0678449

object_name: Tinnitus, CTCAE 3.0


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C0964361

subject_name: SonoVue

object_name: Malignant neoplasm of overlapping sites of breast


subject: CHEBI:30496

subject_name: Sulfur hexafluoride


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Atopic disorders


subject: UMLS:C3658854


subject: CHEBI:47780

subject_name: Clomipramine

object_name: Compulsion


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: autoimmune encephalitis


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: uveitis


subject: CHEBI:168396

object_name: Uveitis, CTCAE


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: UNII:8Z13S29R5A

subject_name: lumiliximab

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C1327944


subject: UMLS:C0034805

subject_name: Fc Receptor


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: Oral Complication


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate

object_name: Neck Carcinoma


subject: UMLS:C1706792

object_name: head and neck neoplasm


subject: UMLS:C1706792

object_name: head and neck cancer


subject: UMLS:C1706792


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:45863

subject_name: Paclitaxel


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: complications of organ transplant stem cells


subject: PUBCHEM.COMPOUND:2735

object_name: childhood malignant neoplasm


subject: PUBCHEM.COMPOUND:2735

object_name: Thalassemia in children


subject: PUBCHEM.COMPOUND:2735

object_name: Sickle cell anemia in children


subject: PUBCHEM.COMPOUND:2735

object_name: childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:2735

object_name: childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:2735

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:2735

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: PUBCHEM.COMPOUND:2735

object_name: aplastic anemia


subject: PUBCHEM.COMPOUND:2735

object_name: idiopathic aplastic anemia


subject: PUBCHEM.COMPOUND:2735

object_name: hematologic disorder


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: DRUGBANK:DB10543

subject_name: Cow milk

object_name: asthma


subject: UMLS:C5556781

subject_name: Anti-PD-1/Anti-TIM-3 Bispecific Antibody AZD7789

object_name: Gastroesophageal junction cancer


subject: UMLS:C5556781

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:11281445

subject_name: NAVARIXIN


subject: PUBCHEM.COMPOUND:168310632

subject_name: Navarixin


subject: PUBCHEM.COMPOUND:393472

subject_name: Acetogenins

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:393472

object_name: prostate cancer


subject: CHEBI:167650

object_name: Childhood Solid Neoplasm


subject: CHEBI:167650

object_name: Adult Solid Neoplasm


subject: CHEBI:167650

object_name: Solid Neoplasm


subject: UMLS:C4745029

subject_name: HLX 10

object_name: liver carcinoma


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: blindness


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: Bone atrophy


subject: CHEBI:132268

subject_name: Dacomitinib

object_name: metastatic malignant neoplasm in the brain


subject: UNII:4I9I5X3Z6N

subject_name: VUDALIMAB

object_name: ovarian cancer


subject: UNII:4I9I5X3Z6N

object_name: ovarian neoplasm


subject: UNII:4I9I5X3Z6N

object_name: ovarian carcinoma


subject: UNII:4I9I5X3Z6N

object_name: endometrial cancer


subject: UNII:4I9I5X3Z6N

object_name: uterine corpus cancer


subject: UNII:4I9I5X3Z6N

object_name: endometrial carcinoma


subject: UNII:4I9I5X3Z6N

object_name: suppressor of tumorigenicity 3


subject: UNII:4I9I5X3Z6N

object_name: cervical carcinoma


subject: UNII:4I9I5X3Z6N

object_name: endometrial clear cell adenocarcinoma


subject: UNII:4I9I5X3Z6N

object_name: clear cell adenocarcinoma


subject: UMLS:C4725753

subject_name: Vudalimab


subject: UMLS:C4725753


subject: UMLS:C4725753


subject: UMLS:C4725753


subject: UMLS:C4725753


subject: UMLS:C4725753


subject: UMLS:C4725753


subject: UMLS:C4725753


subject: UMLS:C4725753


subject: UMLS:C4725753


subject: UMLS:C4764260

subject_name: PI3K-delta Inhibitor YY-20394

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4764260

object_name: B-cell lymphoma recurrent


subject: UMLS:C4309517

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C3641624

subject_name: XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:32231

subject_name: Tipepidine hibenzate

object_name: Depressed mood


subject: CHEBI:32231

object_name: Cancer patients and suicide and depression


subject: CHEBI:32231

object_name: Depressed - symptom


subject: CHEBI:32231

object_name: Depression, CTCAE


subject: CHEBI:135141

subject_name: Tipepidine


subject: CHEBI:135141


subject: CHEBI:135141


subject: CHEBI:135141


subject: UMLS:C0145968

subject_name: tipepidine hibenzate


subject: UMLS:C0145968


subject: UMLS:C0145968


subject: UMLS:C0145968


subject: CHEBI:84040

object_name: acute pancreatitis


subject: CHEBI:84040

object_name: digestive system disorder


subject: CHEBI:84040

object_name: gastrointestinal disease


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:27881


subject: CHEBI:9927

subject_name: Valsartan

object_name: hyperlipidemia


subject: CHEBI:9927

object_name: hyperlipoproteinemia


subject: CHEBI:9927

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:9927

object_name: Serum lipids high (finding)


subject: UMLS:C5418111


subject: CHEBI:4911

subject_name: Etoposide

object_name: Stomach cancer


subject: CHEBI:4911

object_name: gastric cancer


subject: CHEBI:4911

object_name: gastric neoplasm


subject: UMLS:C5441821

subject_name: Farmorubicin


subject: UMLS:C5441821


subject: UMLS:C5441821


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:50692

subject_name: Mifepristone

object_name: cancer


subject: CHEBI:50692

object_name: neoplasm


subject: CHEBI:109549

subject_name: Ramelteon

object_name: endogenous depression


subject: CHEBI:109549

object_name: major depressive disorder


subject: MESH:D022242

subject_name: Pneumococcal Vaccines

object_name: leukemia


subject: MESH:D022242

object_name: childhood leukemia


subject: UMLS:C5240157

subject_name: Vaccine product containing only Streptococcus pneumoniae antigen (medicinal product)


subject: UMLS:C5240157


subject: UMLS:C5564711

object_name: sleep apnea


subject: UMLS:C5564711

object_name: Sleep Apnea, CTCAE


subject: CHEBI:31355

subject_name: Carboplatin

object_name: pediatric osteosarcoma


subject: CHEBI:31355

object_name: Osteosarcoma


subject: UMLS:C5544290

object_name: Chronic small plaque psoriasis


subject: UMLS:C5544290

object_name: psoriasis


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: lung large cell carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: minimally invasive lung adenocarcinoma


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672

object_name: lung adenocarcinoma


subject: CHEBI:4911


subject: CHEBI:4911

object_name: squamous cell lung carcinoma


subject: CHEBI:4911


subject: CHEBI:4911


subject: UMLS:C2002885

subject_name: Iminoral

object_name: end stage renal failure


subject: UMLS:C2002885

object_name: Chronic uremia


subject: MESH:D014765

subject_name: Viral Vaccines

object_name: influenza A


subject: CHEBI:5931

subject_name: insulin human

object_name: Acute Stroke


subject: CHEBI:5931

object_name: Acute Stroke Related to COVID-19


subject: UMLS:C0876064

subject_name: Lantus


subject: UMLS:C0876064


subject: CHEBI:82339

subject_name: Merphalan

object_name: metastatic melanoma


subject: CHEBI:28876

subject_name: Melphalan


subject: UMLS:C0556108

subject_name: Soluble fibre supplementation

object_name: cystic fibrosis


subject: UMLS:C0556108

object_name: cystic fibrosis-related diabetes


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: persian gulf syndrome


subject: CHEBI:17858

subject_name: oxiglutatione


subject: CHEBI:177535

subject_name: L-Glutathione (reduced)


subject: CHEBI:57925


subject: CHEBI:177258

subject_name: Cytidine 2',3'-cyclic phosphate


subject: CHEBI:16856

subject_name: Glutathione


subject: UNII:V7YQ6134AE

object_name: ovarian cancer


subject: UNII:V7YQ6134AE

object_name: ovarian neoplasm


subject: UNII:V7YQ6134AE

object_name: ovarian carcinoma


subject: CHEBI:27432

subject_name: linolenic acid

object_name: arteriosclerosis disorder


subject: CHEBI:27432

object_name: atherosclerosis


subject: CHEBI:27432

object_name: morbid obesity


subject: CHEBI:30314

subject_name: Lipoic acid


subject: CHEBI:30314


subject: CHEBI:30314


subject: CHEBI:46217

subject_name: L-alanine residue


subject: CHEBI:158283

subject_name: Ala-Leu-Ala


subject: CHEBI:158283


subject: CHEBI:158283


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:17549

subject_name: Aminolevulinic acid


subject: CHEBI:17549


subject: CHEBI:17549


subject: CHEBI:16977

subject_name: Alanine


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: CD274 Gene Mutation


subject: UMLS:C3827082


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:9907

subject_name: ursodiol

object_name: rheumatoid arthritis


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: colorectal cancer


subject: UMLS:C0919079

object_name: colorectal carcinoma


subject: UMLS:C0919079

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:3219

subject_name: Bupropion

object_name: Cannabis use disorder


subject: CHEBI:3219

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:3219


subject: UMLS:C1174751

subject_name: Certican

object_name: Disorder related to renal transplantation


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Craniofacial Abnormalities


subject: CHEBI:4466

object_name: Micrognathia


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:2453

subject_name: Acyclovir

object_name: uveitis


subject: CHEBI:2453

object_name: Uveitis, CTCAE


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Upper Respiratory Infections


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C2984033

object_name: Carcinoma breast stage IV


subject: CHEMBL.COMPOUND:CHEMBL2108570

subject_name: ABOBOTULINUMTOXINA

object_name: adolescent idiopathic scoliosis


subject: CHEMBL.COMPOUND:CHEMBL2108570

object_name: scoliosis, isolated, susceptibility to, 1


subject: UMLS:C2729275

subject_name: INJECTION, ABOBOTULINUMTOXINA, 5 UNITS


subject: UMLS:C2729275


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: primary systemic amyloidosis


subject: CHEBI:133021

subject_name: Venetoclax


subject: UMLS:C3541386

subject_name: Estrogens, endocrine therapy drugs

object_name: infertility


subject: UMLS:C3537250

subject_name: ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM


subject: CHEBI:50114

subject_name: estrogen


subject: UMLS:C3714615

subject_name: Estrogens Drug Class


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Leukemia - acute lymphoblastic leukemia (ALL)


subject: CHEBI:41879

object_name: adult acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905

object_name: acute lymphoblastic leukemia


subject: CHEBI:230905


subject: CHEBI:230905


subject: UMLS:C5557246

subject_name: KRAS G12C Inhibitor LY3537982

object_name: kidney failure


subject: GTOPDB:8966

subject_name: onartuzumab

object_name: Stomach cancer


subject: GTOPDB:8966

object_name: gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL1743051

subject_name: ONARTUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743051


subject: UMLS:C2826110


subject: UMLS:C2826110


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: castration-resistant prostate carcinoma


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: heart failure


subject: CHEBI:46245

object_name: congestive heart failure


subject: CHEBI:230508

subject_name: birabresib

object_name: glioblastoma


subject: CHEBI:230508

object_name: Brain Stem Glioblastoma


subject: CHEBI:230508

object_name: glioma susceptibility 1


subject: UNII:J241Y80EEO

subject_name: Emraclidine

object_name: schizophrenia


subject: UNII:J241Y80EEO

object_name: Blood Pressure Finding


subject: UNII:J241Y80EEO

object_name: Systemic arterial pressure


subject: UMLS:C5881707


subject: UMLS:C5881707


subject: UMLS:C5881707


subject: UNII:8F5X4B082E

subject_name: Lixivaptan


subject: UNII:8F5X4B082E


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: osteoarthritis susceptibility 1


subject: CHEBI:3215

object_name: osteoarthritis, knee


subject: CHEBI:3215

object_name: Osteoarthrosis Deformans


subject: CHEBI:3215

object_name: Kashin-Beck disease


subject: UMLS:C4752989

subject_name: Dupilumab only product

object_name: atopic eczema


subject: UMLS:C4752989

object_name: Alzheimer disease type 1


subject: UMLS:C4752989

object_name: Alzheimer disease


subject: UMLS:C4752989

object_name: Alzheimer disease 3


subject: UMLS:C4752989

object_name: Admitting diagnosis


subject: UMLS:C4752989

object_name: dermatitis


subject: UMLS:C4752989

object_name: Eczema, CTCAE


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: diffuse large B-cell lymphoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Locally Advanced Gastric Carcinoma


subject: UNII:621XR2W6OP

subject_name: Methylprednisone

object_name: Intestinal Graft Versus Host Disease


subject: PUBCHEM.COMPOUND:5126752


subject: CHEBI:135573

subject_name: Meprednisone


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: PUBCHEM.COMPOUND:91976568

subject_name: Teduglutide

object_name: graft versus host disease


subject: UMLS:C1098514


subject: CHEBI:90881

subject_name: Camptosar

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:90881

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:90881

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: GTOPDB:9244

subject_name: utomilumab


subject: GTOPDB:9244


subject: GTOPDB:9244


subject: GTOPDB:9244


subject: GTOPDB:9244


subject: CHEMBL.COMPOUND:CHEMBL3707324

subject_name: UTOMILUMAB


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: CHEMBL.COMPOUND:CHEMBL3707324


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: UMLS:C3529795


subject: CHEBI:6824

subject_name: Methenamine

object_name: Lower urinary tract infectious disease


subject: CHEBI:6824

object_name: bacterial urinary tract infection


subject: CHEBI:6824

object_name: Female Urogenital Diseases


subject: CHEBI:39867

subject_name: Valproic acid

object_name: Acute Ischemic Stroke


subject: CHEBI:39867

object_name: Ischemic stroke


subject: CHEBI:95165

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:95165

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:95165

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: UMLS:C4721901

subject_name: Lanreotide Autogel

object_name: neuroendocrine neoplasm


subject: CHEBI:91425

object_name: neoplasm


subject: CHEBI:177770

subject_name: Ganetespib

object_name: myeloproliferative neoplasm


subject: CHEBI:177770

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:177770

object_name: chronic leukemia


subject: CHEBI:177770

object_name: Myelodysplasia


subject: CHEBI:177770

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:177770

object_name: myoclonic dystonia 11


subject: CHEBI:177770

object_name: acute myeloid leukemia


subject: UMLS:C2830057

subject_name: c-Met/VEGFR-2 Kinase Inhibitor E7050

object_name: cancer


subject: UMLS:C2830057


subject: CHEBI:136050

subject_name: Ozenoxacin

object_name: impetigo


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Paroxysmal dyspnea


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Insulin resistance


subject: CHEBI:5001

object_name: Burn injury


subject: UMLS:C5417870

subject_name: Exlinkibart

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C5417870

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C5417870

object_name: sarcoma


subject: UMLS:C5417870

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C5417870

object_name: soft tissue sarcoma


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: cholecystitis


subject: CHEBI:3215

object_name: Cholecystitis, CTCAE 3.0


subject: CHEBI:3215

object_name: Cholecystitis, CTCAE 5.0


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: pyoderma gangrenosum


subject: CHEBI:34718

subject_name: Dinitrochlorobenzene

object_name: HIV infection


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Non-metastatic prostate cancer


subject: CHEBI:233362

object_name: metastatic prostate carcinoma


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix


subject: UMLS:C0971731


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Antibiotic-associated diarrhea


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: Childhood Breast Carcinoma


subject: DRUGBANK:DB14101

object_name: breast carcinoma


subject: DRUGBANK:DB14101

object_name: breast cancer


subject: UMLS:C0677666

subject_name: soy protein isolate


subject: UMLS:C0677666


subject: UMLS:C0677666


subject: CHEBI:197437

subject_name: Mocetinostat

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:197437

object_name: rhabdomyosarcoma


subject: CHEBI:197437

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:197437

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: GTOPDB:4985

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: CHEBI:7773

subject_name: Ondansetron

object_name: dehydration (Na, H2O)


subject: CHEBI:7773

object_name: Dehydration, CTCAE


subject: CHEBI:7773

object_name: Dehydration


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Cardiac complication


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: oropharyngeal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: oropharynx cancer


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: human papilloma virus infection


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: PUBCHEM.COMPOUND:146361282

object_name: classic congenital adrenal hyperplasia


subject: PUBCHEM.COMPOUND:146361282

object_name: adrenogenital syndrome


subject: PUBCHEM.COMPOUND:146361282

object_name: congenital adrenal hyperplasia


subject: UNII:NR57FH6U1N

subject_name: ATUMELNANT


subject: UNII:NR57FH6U1N


subject: UNII:NR57FH6U1N


subject: UMLS:C5854550

subject_name: ACTH Antagonist CRN04894


subject: UMLS:C5854550


subject: UMLS:C5854550


subject: CHEBI:4315

subject_name: Danazol

object_name: endometriosis


subject: CHEBI:4315

object_name: ovarian cyst


subject: CHEBI:4315

object_name: infertility


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:46783403

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:46783403

object_name: Childhood Rectal Carcinoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Childhood Anaplastic Oligodendroglioma


subject: CHEBI:31355

object_name: anaplastic oligodendroglioma


subject: CHEBI:31355

object_name: Adult Anaplastic Oligodendroglioma


subject: UMLS:C1384659


subject: UMLS:C1384659


subject: UMLS:C1384659


subject: UMLS:C1384659

object_name: glioblastoma


subject: UMLS:C1384659

object_name: Brain Stem Glioblastoma


subject: UMLS:C1384659

object_name: glioma susceptibility 1


subject: UMLS:C1384659

object_name: Grade III Childhood Astrocytoma


subject: UMLS:C1384659

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C1384659

object_name: anaplastic astrocytoma


subject: UMLS:C1384659

object_name: Adult Gliosarcoma


subject: UMLS:C1384659

object_name: gliosarcoma


subject: UMLS:C1384659

object_name: Childhood Gliosarcoma


subject: CHEBI:49960

subject_name: Vandetanib


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: diabetic kidney disease


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: dermatitis


subject: UNII:71492GE1FX

object_name: Eczema, CTCAE


subject: UNII:71492GE1FX

object_name: Dermatitis


subject: UNII:71492GE1FX

object_name: skin disorder


subject: UNII:71492GE1FX

object_name: Skin Diseases, Eczematous


subject: UNII:71492GE1FX

object_name: Genodermatosis


subject: UNII:71492GE1FX

object_name: genetic disease


subject: UNII:71492GE1FX

object_name: immune system disorder


subject: UNII:71492GE1FX

object_name: IgE responsiveness, atopic


subject: UNII:71492GE1FX

object_name: Allergy


subject: UNII:71492GE1FX

object_name: hypersensitivity reaction disease


subject: UNII:71492GE1FX

object_name: Emotional hypersensitivity


subject: CHEBI:8426

subject_name: Probenecid


subject: CHEBI:31547

subject_name: Eplerenone

object_name: Overweight and obesity


subject: CHEBI:31547

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:31547

object_name: metabolic syndrome X


subject: UNII:609AWV0US2

object_name: adult acute respiratory distress syndrome


subject: CHEMBL.COMPOUND:CHEMBL4297701


subject: UMLS:C4745025


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: rosacea


subject: CHEBI:3160

object_name: Erythema


subject: UMLS:C2346492

subject_name: Indocyanine Green Solution

object_name: endometrial cancer


subject: UMLS:C2346492

object_name: uterine corpus cancer


subject: UMLS:C2346492

object_name: endometrial carcinoma


subject: UMLS:C2346492

object_name: Sentinel node (disorder)


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Sexual Arousal Disorder


subject: CHEBI:192614

object_name: psychosexual disorder


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:46195

object_name: Embolism, Tumor


subject: CHEBI:46195

object_name: Neoplasm Metastasis


subject: CHEBI:46195

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: UNII:J1J4P3PQZD


subject: UNII:J1J4P3PQZD

object_name: Coronavinae infectious disease


subject: UMLS:C4519731


subject: UMLS:C4519731


subject: CHEBI:55438

subject_name: Angiotensin 1-7


subject: CHEBI:55438


subject: UMLS:C0103306


subject: UMLS:C0103306


subject: CHEBI:229223

subject_name: Daprodustat

object_name: peripheral vascular disease


subject: UMLS:C4043356


subject: CHEBI:177833

subject_name: Cilengitide

object_name: Recurrent Adult Brain Neoplasm


subject: UMLS:C0764377


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: liver cancer


subject: CHEBI:175901

object_name: Adult Liver Carcinoma


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: CHEBI:95021

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: CHEBI:95021

object_name: gallbladder cancer


subject: CHEBI:95021

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: CHEBI:95021

object_name: Stage III Gallbladder Cancer AJCC v8


subject: CHEBI:95021

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: CHEBI:95021

object_name: gallbladder carcinoma


subject: CHEBI:95021

object_name: extrahepatic bile duct carcinoma


subject: CHEBI:95021

object_name: malignant tumor of extrahepatic bile duct


subject: CHEBI:32682

subject_name: L-argininium

object_name: asthma


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: UMLS:C2931954

subject_name: MLC 901

object_name: Cognitive impairment


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: acute coronary syndrome


subject: UMLS:C0358855

object_name: Recurrence


subject: UMLS:C0358855

object_name: Recurrent Malignant Neoplasm


subject: UMLS:C0358855

object_name: Recurrent disease


subject: UMLS:C0358855

object_name: Recurrent tumor


subject: GTOPDB:12990

subject_name: sintilimab

object_name: head and neck squamous cell carcinoma


subject: GTOPDB:12990

object_name: Embolism, Tumor


subject: GTOPDB:12990

object_name: Neoplasm Metastasis


subject: GTOPDB:12990

object_name: Metastatic Lesion


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: progressive supranuclear palsy


subject: CHEBI:9168

subject_name: Sirolimus

object_name: pulmonary branch stenosis


subject: CHEBI:9168

object_name: Peripheral pulmonary artery stenosis


subject: CHEBI:70839

subject_name: Dasatinib

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:91398

subject_name: Tivantinib

object_name: Hepatic impairment


subject: CHEBI:91398

object_name: Childhood Solid Neoplasm


subject: CHEBI:91398

object_name: Solid Neoplasm


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:52717

object_name: stage IV pancreatic cancer


subject: CHEBI:52717

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:52717

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5907971

subject_name: Anti-HER3 Antibody-drug Conjugate SHR-A2009

object_name: Childhood Breast Carcinoma


subject: UMLS:C5907971

object_name: breast carcinoma


subject: UMLS:C5907971

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL4297828


subject: CHEMBL.COMPOUND:CHEMBL4297828


subject: CHEMBL.COMPOUND:CHEMBL4297828


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid


subject: CHEBI:231005

object_name: childhood malignant neoplasm


subject: CHEBI:231005

object_name: adult lymphoma


subject: CHEBI:231005

object_name: lymphoma


subject: CHEBI:231005

object_name: pediatric lymphoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: MESH:D002800

subject_name: Cholinesterase Inhibitors

object_name: Presenile dementia


subject: MESH:D002800

object_name: dementia


subject: UMLS:C3536756

subject_name: Cholinesterase Inhibitor [EPC]

object_name: Alzheimer disease


subject: UMLS:C3536756


subject: UMLS:C3536756


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: anemia


subject: CHEBI:63791

object_name: Anemia, CTCAE


subject: UMLS:C4755155

subject_name: Ursodiol only product

object_name: polyp of gallbladder


subject: UMLS:C4755155

object_name: Gallbladder polyp


subject: CHEBI:6413

subject_name: Letrozole

object_name: Osteopenia


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:45716

object_name: poorly differentiated thyroid gland carcinoma


subject: CHEBI:45716

object_name: Stage II Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:45716

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:45716

object_name: Stage II Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:45716

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:45716

object_name: medullary thyroid gland carcinoma


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: hypoglycemia


subject: CHEBI:135285

object_name: Blood glucose below reference range (finding)


subject: CHEBI:135285

object_name: Hypoglycemia, CTCAE


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Stomach cancer


subject: UNII:8M7YSN2KII

object_name: gastric cancer


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: PUBCHEM.COMPOUND:9803433

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:9803433

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:9803433

object_name: breast cancer


subject: UNII:9JD9B4S53T


subject: UNII:9JD9B4S53T


subject: UNII:9JD9B4S53T


subject: UMLS:C1614561

subject_name: Polypodium leucotomos

object_name: Melasma


subject: CHEBI:231416

subject_name: Danicopan

object_name: kidney failure


subject: CHEBI:231416

object_name: Renal dysfunction


subject: PUBCHEM.COMPOUND:58641927

subject_name: Ulixertinib

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:58641927

object_name: Advanced Lymphoma


subject: PUBCHEM.COMPOUND:58641927

object_name: Refractory Lymphoma


subject: UMLS:C4287812

subject_name: ulixertinib


subject: UMLS:C4287812


subject: UMLS:C4287812


subject: UMLS:C4733108

subject_name: Navelbine Oral


subject: UMLS:C4733108


subject: UMLS:C4733108


subject: CHEBI:27446

subject_name: Penicillin V

object_name: Increased reactive oxygen species production


subject: CHEBI:45924

subject_name: Trimethoprim


subject: PR:000022493

object_name: hepatitis B


subject: PUBCHEM.COMPOUND:77335690

subject_name: Velpatasvir


subject: PUBCHEM.COMPOUND:77335690

object_name: HIV infection


subject: CHEBI:18385

subject_name: Thiamine

object_name: Injury of kidney


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: acute myocardial infarction


subject: PUBCHEM.COMPOUND:70105374

object_name: Acute Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:70105374

object_name: glucose metabolism disease


subject: CHEBI:32020

subject_name: Pitavastatin


subject: CHEBI:32020


subject: CHEBI:32020


subject: PUBCHEM.COMPOUND:122316

object_name: retinal detachment


subject: PUBCHEM.COMPOUND:122316

object_name: Retinal Detachment, CTCAE 3.0


subject: PUBCHEM.COMPOUND:122316

object_name: Retinal Detachment, CTCAE 5.0


subject: CHEBI:63620

subject_name: Rasagiline


subject: CHEBI:63620


subject: CHEBI:63620


subject: MESH:D056692

subject_name: Prebiotics

object_name: Muscle Atrophy


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Stage I Pancreatic Cancer AJCC v6 and v7


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: MESH:C520255

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: MESH:C520255

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: MESH:C520255

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: MESH:C520255

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:91899

object_name: autoimmune hepatitis


subject: CHEBI:3207

subject_name: Budesonide


subject: UMLS:C5556341

subject_name: MAT2A Inhibitor IDE397

object_name: esophageal adenocarcinoma


subject: UMLS:C5556341

object_name: Barrett esophagus


subject: UMLS:C5556341

object_name: non-small cell lung carcinoma


subject: UMLS:C5556341

object_name: gastric adenocarcinoma


subject: UMLS:C5556341

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5556341

object_name: peritoneal mesothelioma


subject: UMLS:C5556341

object_name: malignant peritoneal mesothelioma


subject: UMLS:C5556341

object_name: pleural mesothelioma


subject: UMLS:C5556341

object_name: malignant pleural mesothelioma


subject: UMLS:C5556341

object_name: bladder tumor


subject: UMLS:C5556341

object_name: urinary bladder carcinoma


subject: UMLS:C5556341

object_name: urinary bladder cancer


subject: UMLS:C5556341

object_name: childhood bladder carcinoma


subject: UMLS:C5556341

object_name: Mesothelioma


subject: UMLS:C5556341

object_name: mesothelial neoplasm


subject: UMLS:C5556341

object_name: malignant mesothelioma


subject: CHEBI:188804

subject_name: Telapristone acetate

object_name: endometriosis


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: Fractured tibia


subject: PUBCHEM.COMPOUND:3467

object_name: Osteomyelitis of tibia


subject: CHEBI:9932

subject_name: Vancomycin hydrochloride


subject: CHEBI:9932


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: UMLS:C0205992

subject_name: vancomycin hydrochloride


subject: UMLS:C0205992


subject: GTOPDB:4934

subject_name: G-CSF

object_name: chronic liver failure


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:40799

subject_name: Boldione

object_name: Oligometastatic malignant neoplasm


subject: CHEBI:177298

object_name: prostate carcinoma


subject: CHEBI:177298

object_name: prostate cancer


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: UMLS:C1176237

subject_name: Exubera

object_name: type 1 diabetes mellitus 1


subject: UMLS:C1176237

object_name: type 1 diabetes mellitus


subject: CHEBI:63635

subject_name: Valganciclovir

object_name: kidney disorder


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: lymphoid neoplasm


subject: UMLS:C0003442

object_name: CD20 Positive


subject: CHEBI:52717

subject_name: Bortezomib

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:52717

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:3423

subject_name: Carmustine


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: UNII:PVI5M0M1GW


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: chronic hepatitis B virus infection


subject: UNII:7D0YB67S97

object_name: hepatitis B


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: atopic eczema


subject: CHEBI:231614

subject_name: Nivolumab

object_name: chronic leukemia


subject: CHEBI:231614

object_name: acute leukemia


subject: CHEBI:231614

object_name: adult lymphoma


subject: CHEBI:231614

object_name: lymphoma


subject: CHEBI:231614

object_name: pediatric lymphoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:52763

object_name: Myelodysplasia


subject: CHEBI:52763


subject: CHEBI:52763


subject: CHEBI:52763


subject: CHEBI:52763


subject: CHEBI:52763


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:73604


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:P0GVQ9A4S5

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Cognitive impairment


subject: CHEBI:50733

object_name: debility; old age


subject: CHEBI:61606


subject: CHEBI:61606


subject: PUBCHEM.COMPOUND:53477767

subject_name: Hesperidin


subject: PUBCHEM.COMPOUND:53477767


subject: UMLS:C4688598

object_name: non-small cell lung carcinoma


subject: UMLS:C5783474

subject_name: IRAK4/Ikaros/Aiolos Protein Degrader KT-413

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5783474

object_name: MYD88 Gene Mutation


subject: UMLS:C5783474

object_name: non-Hodgkin lymphoma


subject: UNII:OYK17DYO9M

subject_name: Carotegrast

object_name: ulcerative colitis


subject: UNII:OYK17DYO9M

object_name: inflammatory bowel disease 1


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: vulvar lichen sclerosus


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: UMLS:C2756587

subject_name: soy

object_name: Childhood Breast Carcinoma


subject: UMLS:C2756587

object_name: breast carcinoma


subject: UMLS:C2756587

object_name: breast cancer


subject: UMLS:C1697820

subject_name: soy - non-drug agent


subject: UMLS:C1697820


subject: UMLS:C1697820


subject: CHEBI:63631

subject_name: Topiramate

object_name: Vomiting, CTCAE


subject: CHEBI:63631

object_name: Vomiting


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: nicotine dependence


subject: CHEBI:25681

object_name: Tabagism


subject: UNII:V16D2ZT7DT

object_name: acute lymphoblastic leukemia


subject: UNII:V16D2ZT7DT

object_name: acute myeloid leukemia


subject: CHEBI:39585

subject_name: Carbidopa


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: stomach carcinoma in situ


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:73579

subject_name: Leu-Val

object_name: biliary tract cancer


subject: CHEBI:73579

object_name: pancreatic neoplasm


subject: CHEBI:73579


subject: CHEBI:194537

subject_name: Livermorium


subject: CHEBI:194537


subject: CHEBI:194537


subject: UMLS:C1881413

subject_name: Liposome Vesicle


subject: UMLS:C1881413


subject: UMLS:C1881413


subject: PR:000003915

subject_name: delta-aminolevulinic acid dehydratase


subject: PR:000003915


subject: PR:000003915


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: MESH:C079198

subject_name: S 1 (combination)


subject: UMLS:C4051515

subject_name: PCSK9 Inhibitor [EPC]

object_name: Acute Ischemic Stroke


subject: UMLS:C4051515

object_name: Ischemic stroke


subject: UMLS:C4521460

subject_name: Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action


subject: UMLS:C4521460


subject: CHEBI:31687

subject_name: Idebenone

object_name: Leber hereditary optic neuropathy


subject: CHEBI:6801

subject_name: Metformin

object_name: HER2 positive breast carcinoma


subject: MESH:C000634149

object_name: Recurrent Malignant Neoplasm


subject: MESH:C000634149

object_name: Recurrent Carcinoma


subject: UNII:PF9462I9HX

subject_name: Larotrectinib

object_name: High grade glioma


subject: UNII:PF9462I9HX

object_name: malignant glioma


subject: UNII:PF9462I9HX

object_name: diffuse midline glioma, H3 K27M-mutant


subject: UNII:PF9462I9HX

object_name: diffuse intrinsic pontine glioma


subject: PUBCHEM.COMPOUND:11236066

subject_name: BRIMONIDINE TARTRATE

object_name: hyperemia


subject: CHEBI:3175

subject_name: Brimonidine


subject: MESH:C000632500

subject_name: reolysin

object_name: colorectal cancer


subject: MESH:C000632500

object_name: colorectal carcinoma


subject: MESH:C000632500

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: Patent ductus arteriosus after premature birth


subject: PUBCHEM.COMPOUND:53395955

subject_name: Natrecor

object_name: heart failure


subject: PUBCHEM.COMPOUND:53395955

object_name: congestive heart failure


subject: PUBCHEM.COMPOUND:53395955

object_name: cardiomyopathy


subject: UMLS:C1170421


subject: UMLS:C1170421


subject: UMLS:C1170421


subject: CHEBI:135919

subject_name: Nesiritide


subject: CHEBI:231342

subject_name: ceralasertib

object_name: Stage II Lung Cancer AJCC v8


subject: CHEBI:231342

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:231342

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:149520

subject_name: Polihexanide

object_name: Irreversible pulpitis


subject: CHEBI:24757

subject_name: Hypochlorite


subject: CHEBI:31398

subject_name: ciclopirox olamine

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:31398

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:31398

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:31398

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:31398

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:31398

object_name: acute lymphoblastic leukemia


subject: CHEBI:31398

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:31398

object_name: acute myeloid leukemia


subject: CHEBI:31398

object_name: Myelodysplasia


subject: CHEBI:31398

object_name: Myelodysplasia, CTCAE


subject: CHEBI:31398

object_name: Hodgkin Disease


subject: CHEBI:453011

subject_name: Ciclopirox


subject: CHEBI:453011


subject: CHEBI:453011


subject: CHEBI:453011


subject: CHEBI:453011


subject: CHEBI:453011


subject: CHEBI:453011


subject: CHEBI:453011


subject: CHEBI:453011


subject: CHEBI:453011


subject: CHEBI:453011


subject: UMLS:C5446615

subject_name: ALK2 Inhibitor INCB000928


subject: UMLS:C5446615

object_name: anemia


subject: UMLS:C5446615

object_name: Anemia, CTCAE


subject: UMLS:C5446615

object_name: plasma cell myeloma


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Uses contraception (finding)


subject: CHEBI:6129

object_name: IUD insertion complication


subject: CHEBI:6129

object_name: Fetal Death


subject: CHEBI:2673

subject_name: Amobarbital

object_name: Hemodynamic instability


subject: CHEBI:65346

subject_name: Aclidinium

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C3897258

subject_name: Ubidecarenone Nanodispersion BPM31510n

object_name: sarcopenia


subject: PUBCHEM.COMPOUND:24748

subject_name: Croscarmellose

object_name: cataract


subject: PUBCHEM.COMPOUND:24748

object_name: Cataract, CTCAE 3.0


subject: PUBCHEM.COMPOUND:24748

object_name: Cataract, CTCAE 5.0


subject: PUBCHEM.COMPOUND:24748

object_name: cataract on exam (physical finding)


subject: UNII:K679OBS311

subject_name: Carboxymethylcellulose Sodium


subject: UNII:K679OBS311


subject: UNII:K679OBS311


subject: UNII:K679OBS311


subject: UNII:638KY4573I

object_name: kidney failure


subject: UNII:638KY4573I

object_name: Renal Failure, CTCAE


subject: UNII:PD5EII1F9A

subject_name: Firibastat


subject: UNII:PD5EII1F9A


subject: CHEBI:233413

subject_name: Denifanstat

object_name: Childhood Malignant Solid Neoplasm


subject: CHEBI:233413

object_name: Malignant Solid Neoplasm


subject: MESH:C000717092


subject: MESH:C000717092


subject: PUBCHEM.COMPOUND:23695837

subject_name: Amoxicillin; Clavulanate Potassium

object_name: sinusitis


subject: PUBCHEM.COMPOUND:23695837

object_name: Sinusitis, CTCAE


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: UMLS:C0054066


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UNII:M89N0Q7EQR

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: UNII:M89N0Q7EQR

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UNII:M89N0Q7EQR

object_name: childhood myelodysplastic syndrome


subject: UNII:M89N0Q7EQR

object_name: B-cell adult acute lymphocytic leukemia


subject: UNII:M89N0Q7EQR

object_name: T-cell adult acute lymphocytic leukemia


subject: UNII:M89N0Q7EQR

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UNII:M89N0Q7EQR

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UNII:M89N0Q7EQR

object_name: B-cell childhood acute lymphoblastic leukemia


subject: UNII:M89N0Q7EQR

object_name: T-cell childhood acute lymphocytic leukemia


subject: UNII:M89N0Q7EQR

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UNII:M89N0Q7EQR

object_name: Previously Treated Myelodysplastic Syndrome


subject: UNII:M89N0Q7EQR

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: UNII:M89N0Q7EQR

object_name: recurrent adult acute myeloid leukemia


subject: UNII:M89N0Q7EQR

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UNII:M89N0Q7EQR

object_name: juvenile myelomonocytic leukemia


subject: UNII:M89N0Q7EQR

object_name: chronic myelomonocytic leukemia


subject: UNII:M89N0Q7EQR

object_name: recurrent childhood acute myeloid leukemia


subject: UNII:M89N0Q7EQR

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:M89N0Q7EQR

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:M89N0Q7EQR

object_name: essential thrombocythemia


subject: UNII:M89N0Q7EQR

object_name: refractory anemia with excess blasts in transformation


subject: UNII:M89N0Q7EQR

object_name: myelodysplastic syndrome with excess blasts


subject: UNII:M89N0Q7EQR

object_name: acquired polycythemia vera


subject: PR:000001379

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PR:000001379

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: PR:000001379

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PR:000001379

object_name: childhood myelodysplastic syndrome


subject: PR:000001379

object_name: B-cell adult acute lymphocytic leukemia


subject: PR:000001379

object_name: T-cell adult acute lymphocytic leukemia


subject: PR:000001379

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PR:000001379

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PR:000001379

object_name: B-cell childhood acute lymphoblastic leukemia


subject: PR:000001379

object_name: T-cell childhood acute lymphocytic leukemia


subject: PR:000001379

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PR:000001379

object_name: Previously Treated Myelodysplastic Syndrome


subject: PR:000001379

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: PR:000001379

object_name: recurrent adult acute myeloid leukemia


subject: PR:000001379

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PR:000001379

object_name: juvenile myelomonocytic leukemia


subject: PR:000001379

object_name: chronic myelomonocytic leukemia


subject: PR:000001379

object_name: recurrent childhood acute myeloid leukemia


subject: PR:000001379

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PR:000001379

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PR:000001379

object_name: essential thrombocythemia


subject: PR:000001379

object_name: refractory anemia with excess blasts in transformation


subject: PR:000001379

object_name: myelodysplastic syndrome with excess blasts


subject: PR:000001379

object_name: acquired polycythemia vera


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UMLS:C5700219

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: UMLS:C5700219

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UMLS:C5700219

object_name: childhood myelodysplastic syndrome


subject: UMLS:C5700219

object_name: B-cell adult acute lymphocytic leukemia


subject: UMLS:C5700219

object_name: T-cell adult acute lymphocytic leukemia


subject: UMLS:C5700219

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UMLS:C5700219

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UMLS:C5700219

object_name: B-cell childhood acute lymphoblastic leukemia


subject: UMLS:C5700219

object_name: T-cell childhood acute lymphocytic leukemia


subject: UMLS:C5700219

object_name: Previously Treated Myelodysplastic Syndrome


subject: UMLS:C5700219

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: UMLS:C5700219

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C5700219

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UMLS:C5700219

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C5700219

object_name: chronic myelomonocytic leukemia


subject: UMLS:C5700219

object_name: recurrent childhood acute myeloid leukemia


subject: UMLS:C5700219

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C5700219

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C5700219

object_name: essential thrombocythemia


subject: UMLS:C5700219

object_name: refractory anemia with excess blasts in transformation


subject: UMLS:C5700219

object_name: myelodysplastic syndrome with excess blasts


subject: UMLS:C5700219

object_name: acquired polycythemia vera


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: endogenous depression


subject: CHEBI:135285

object_name: major depressive disorder


subject: CHEBI:9150

subject_name: Simvastatin

object_name: chronic obstructive pulmonary disease


subject: UNII:2TG7ZF9DBT

subject_name: MAPA

object_name: cytomegalovirus infection


subject: PR:000009934

subject_name: leucine-rich repeat-containing protein 25


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: extranodal nasal NK/T cell lymphoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:144094

subject_name: bicalutamide

object_name: breast neoplasm


subject: UMLS:C2830146

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C2830146


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: adult lymphoma


subject: GTOPDB:9592

object_name: lymphoma


subject: GTOPDB:9592

object_name: pediatric lymphoma


subject: GTOPDB:9592

object_name: leukemia


subject: GTOPDB:9592

object_name: childhood leukemia


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: UNII:AG9MHG098Z


subject: UMLS:C4329341

subject_name: Renvistobart

object_name: Childhood Solid Neoplasm


subject: UMLS:C4329341

object_name: Adult Solid Neoplasm


subject: UMLS:C4329341

object_name: Solid Neoplasm


subject: UMLS:C4329341

object_name: Neck Carcinoma


subject: UMLS:C4329341

object_name: head and neck neoplasm


subject: UMLS:C4329341

object_name: head and neck cancer


subject: UMLS:C4329341

object_name: endometrium neoplasm


subject: UMLS:C4329341

object_name: ovarian cancer


subject: UMLS:C4329341

object_name: ovarian neoplasm


subject: UMLS:C4329341

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594330

subject_name: DAXDILIMAB

object_name: discoid lupus erythematosus


subject: UMLS:C5420897

subject_name: Daxdilimab


subject: CHEBI:6909

subject_name: Metronidazole

object_name: Post-Operative Pain


subject: CHEBI:6909

object_name: hemorrhoid


subject: CHEBI:6909

object_name: Hemorrhoids, CTCAE 3.0


subject: CHEBI:6909

object_name: Hemorrhoids, CTCAE 5.0


subject: RXCUI:8375

subject_name: placebo Oral Tablet


subject: RXCUI:8375


subject: RXCUI:8375


subject: CHEBI:124959

subject_name: Tilarginine

object_name: cardiovascular disorder


subject: UMLS:C0069477


subject: UMLS:C0751598

subject_name: Alferon

object_name: renal carcinoma


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate

object_name: malignant glioma


subject: CHEBI:32150


subject: CHEBI:132112


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Drug toxicity


subject: CHEBI:32071

subject_name: Prulifloxacin

object_name: Acute lower urinary tract infection


subject: CHEBI:11909

subject_name: Sepranolone

object_name: neurodegenerative disease


subject: CHEBI:11909

object_name: Alzheimer disease 2


subject: CHEBI:11909

object_name: Alzheimer Disease, Late Onset


subject: CHEBI:11909

object_name: Alzheimer disease


subject: CHEBI:50169

subject_name: Brexanolone


subject: CHEBI:50169


subject: CHEBI:50169


subject: CHEBI:50169


subject: CHEBI:64103

subject_name: sodium butyrate

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:64103

object_name: obesity


subject: CHEBI:64103

object_name: Obesity, CTCAE


subject: CHEBI:64103

object_name: type 2 diabetes mellitus


subject: UMLS:C0142812

subject_name: Sodium Butyrate


subject: UMLS:C0142812


subject: UMLS:C0142812


subject: UMLS:C0142812


subject: CHEBI:30772

subject_name: Butyric Acid


subject: CHEBI:30772


subject: CHEBI:30772


subject: CHEBI:30772


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Plasma cell tumor, malignant


subject: GTOPDB:4934

object_name: plasma cell neoplasm


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Myelodysplasia


subject: CHEBI:40279

object_name: myeloproliferative neoplasm


subject: CHEBI:40279

object_name: plasma cell myeloma


subject: CHEBI:40279


subject: CHEBI:40279


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UMLS:C0003442


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UMLS:C5206553

subject_name: PLK-1 Inhibitor CYC140


subject: UMLS:C5206553

object_name: Chronic lymphocytic leukaemia refractory


subject: UMLS:C5206553

object_name: refractory chronic myelocytic leukemia


subject: UMLS:C5206553

object_name: adult acute lymphoblastic leukemia


subject: UMLS:C5206553

object_name: adult acute myeloid leukemia


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: genotype


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:33380

subject_name: thulium atom

object_name: Allergy to hay


subject: CHEBI:33380

object_name: Atopic rhinitis


subject: CHEBI:33380

object_name: Hay fever


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:74861


subject: CHEBI:74861


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:55460


subject: CHEBI:55460


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: CHEBI:30703


subject: UMLS:C3166394

subject_name: Tm antigen


subject: UMLS:C3166394


subject: UMLS:C3166394


subject: PR:000002105

subject_name: thrombomodulin


subject: PR:000002105


subject: PR:000002105


subject: CHEBI:73807

subject_name: Ala-Phe

object_name: bacterial conjunctivitis


subject: PR:000002181

subject_name: 26S proteasome non-ATPase regulatory subunit 4


subject: PR:000009379

subject_name: kelch-like protein 17


subject: CHEBI:233158

subject_name: Soticlestat

object_name: partial duplication of the long arm of chromosome 15


subject: CHEBI:149509

object_name: Barrett esophagus


subject: CHEBI:3347

subject_name: Candesartan


subject: PUBCHEM.COMPOUND:3222


subject: CHEBI:4784

subject_name: Enalapril


subject: PUBCHEM.COMPOUND:22023730

subject_name: Ganaxolone

object_name: tuberous sclerosis


subject: PUBCHEM.COMPOUND:22023730

object_name: situs inversus


subject: UMLS:C4733036

subject_name: Medihoney

object_name: kidney failure


subject: UMLS:C4733036

object_name: Renal Failure, CTCAE


subject: CHEBI:66910

subject_name: Axitinib

object_name: glioblastoma


subject: CHEBI:66910

object_name: Brain Stem Glioblastoma


subject: CHEBI:66910

object_name: glioma susceptibility 1


subject: CHEBI:2549

subject_name: Albuterol

object_name: ischemic cardiomyopathy


subject: CHEBI:2549

object_name: Heart Failure, CTCAE


subject: CHEBI:2549

object_name: Non-ischaemic cardiomyopathy


subject: CHEBI:75922

subject_name: Nepafenac

object_name: Disorder of intraocular pressure


subject: CHEBI:75922

object_name: Intraocular Pressure


subject: CHEBI:90844

subject_name: Selexipag

object_name: chronic thromboembolic pulmonary hypertension


subject: GTOPDB:8966

subject_name: onartuzumab

object_name: lung cancer


subject: GTOPDB:8966

object_name: lung neoplasm


subject: GTOPDB:8966

object_name: lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743051

subject_name: ONARTUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743051


subject: CHEMBL.COMPOUND:CHEMBL1743051


subject: UMLS:C2826110


subject: UMLS:C2826110


subject: UMLS:C2826110


subject: UMLS:C5667043

subject_name: Bcl-2/Bcl-XL Inhibitor LP-118


subject: UMLS:C5667043

object_name: Richter syndrome


subject: UMLS:C5667043

object_name: Chronic Myelomonocytic Leukemia-2


subject: UMLS:C5667043

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5667043

object_name: acute lymphoblastic leukemia


subject: UMLS:C5667043

object_name: plasma cell myeloma


subject: UMLS:C5667043

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5667043

object_name: acute myeloid leukemia


subject: UMLS:C5667043

object_name: non-Hodgkin lymphoma


subject: UMLS:C5667043

object_name: myelofibrosis


subject: CHEBI:33539

subject_name: Thiosulfate

object_name: Neoplasm Metastasis


subject: CHEBI:33539


subject: CHEBI:16094


subject: CHEBI:16094


subject: CHEBI:26977

subject_name: thiosulfate


subject: CHEBI:26977


subject: MESH:D013885

subject_name: Thiosulfates


subject: MESH:D013885


subject: CHEBI:132112


subject: CHEBI:132112


subject: PUBCHEM.COMPOUND:6012

subject_name: Durandro

object_name: Rotator cuff tear


subject: CHEBI:17347

subject_name: Testosterone


subject: UNII:IZY9ZSI6FI

subject_name: ZILOVERTAMAB VEDOTIN

object_name: Her2-receptor negative breast cancer


subject: UNII:IZY9ZSI6FI

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UNII:IZY9ZSI6FI

object_name: pancreatic neoplasm


subject: UNII:IZY9ZSI6FI

object_name: exocrine pancreatic carcinoma


subject: UNII:IZY9ZSI6FI

object_name: malignant pancreatic neoplasm


subject: UNII:IZY9ZSI6FI

object_name: estrogen receptor-negative breast cancer


subject: UNII:IZY9ZSI6FI

object_name: Stomach cancer


subject: UNII:IZY9ZSI6FI

object_name: gastric cancer


subject: UNII:IZY9ZSI6FI

object_name: triple-negative breast carcinoma


subject: UNII:IZY9ZSI6FI

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:IZY9ZSI6FI

object_name: non-small cell lung carcinoma


subject: UNII:IZY9ZSI6FI

object_name: progesterone receptor-negative breast cancer


subject: UNII:IZY9ZSI6FI

object_name: estrogen-receptor positive breast cancer


subject: UNII:IZY9ZSI6FI

object_name: progesterone-receptor positive breast cancer


subject: UNII:IZY9ZSI6FI

object_name: estrogen-receptor negative breast cancer


subject: UNII:IZY9ZSI6FI

object_name: progesterone-receptor negative breast cancer


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: UMLS:C4763844


subject: CHEBI:51770

subject_name: Sultamicillin

object_name: chronic obstructive pulmonary disease


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: atrial septal defect


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:39475

subject_name: pentamethyldiethylenetriamine

object_name: Post-Operative Pain


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Arrested active phase of labor


subject: MESH:C514428

subject_name: belagenpumatucel L

object_name: lung cancer


subject: MESH:C514428

object_name: lung neoplasm


subject: MESH:C514428

object_name: bronchogenic carcinoma


subject: CHEBI:17026

subject_name: Progesterone

object_name: female puberty


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: PR:000030332

subject_name: E3 ubiquitin-protein ligase TRIM31

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:134689

subject_name: Rucaparib

object_name: biliary tract cancer


subject: CHEBI:134689

object_name: liver carcinoma


subject: CHEBI:31348

subject_name: Capecitabine

object_name: lymph node cancer


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:83766

subject_name: Olaparib

object_name: carcinoma of esophagus


subject: CHEBI:167574

subject_name: Semaglutide

object_name: prostate carcinoma


subject: CHEBI:167574

object_name: Prostate cancer recurrent


subject: CHEBI:194186

subject_name: Tirzepatide


subject: CHEBI:194186


subject: UNII:QX0ONY0O9T

subject_name: SIGVOTATUG VEDOTIN

object_name: cervical polyp


subject: UNII:QX0ONY0O9T

object_name: bladder tumor


subject: UNII:QX0ONY0O9T

object_name: ovarian cancer


subject: UNII:QX0ONY0O9T

object_name: ovarian neoplasm


subject: UNII:QX0ONY0O9T

object_name: gastric neoplasm


subject: UMLS:C5908938

subject_name: Sigvotatug vedotin


subject: UMLS:C5908938


subject: UMLS:C5908938


subject: UMLS:C5908938


subject: UMLS:C5908938


subject: UMLS:C5417916


subject: UMLS:C5417916


subject: UMLS:C5417916


subject: UMLS:C5417916


subject: UMLS:C5417916


subject: MESH:C000634027

object_name: Wrinkled face


subject: MESH:C000634027

object_name: Crow's feet


subject: UMLS:C0726406

subject_name: Glycolic Acid 70%

object_name: Melasma


subject: UMLS:C5237051

subject_name: Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10

object_name: plasma cell myeloma


subject: UMLS:C5237051

object_name: Plasma cell myeloma refractory


subject: UMLS:C5237051

object_name: Plasma cell myeloma recurrent


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Low back pain


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:34967

subject_name: Rimonabant

object_name: Fatty Liver


subject: GTOPDB:12989

subject_name: toripalimab

object_name: NK/T-cell lymphoma, nasal and nasal-type


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4321475

subject_name: Ceramide Nanoliposome

object_name: Refractory acute myeloid leukemia


subject: UMLS:C4321475

object_name: Relapsing acute myeloid leukemia


subject: UMLS:C5959805

subject_name: Anti-EGFR/Anti-c-Met Monoclonal Antibody FPI-2053

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5959805

object_name: Metastatic Colorectal Carcinoma


subject: UMLS:C5959805

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5959805

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5959805

object_name: non-small cell lung carcinoma


subject: UMLS:C5959805

object_name: Stomach cancer


subject: UMLS:C5959805

object_name: gastric cancer


subject: UMLS:C5959805

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5959805

object_name: clear cell renal carcinoma


subject: UMLS:C5959805

object_name: renal cell adenocarcinoma


subject: UMLS:C5959805

object_name: renal cell carcinoma


subject: UMLS:C5959807

subject_name: Actinium Ac 225 FPI-2068


subject: UMLS:C5959807


subject: UMLS:C5959807


subject: UMLS:C5959807


subject: UMLS:C5959807


subject: UMLS:C5959807


subject: UMLS:C5959807


subject: UMLS:C5959807


subject: UMLS:C5959807


subject: UMLS:C5959807


subject: UMLS:C5959807


subject: UMLS:C4733594

object_name: interstitial lung disease 1


subject: UMLS:C4733594

object_name: interstitial lung disease 2


subject: UMLS:C4733594

object_name: Hypoxemia


subject: UMLS:C4733594

object_name: Blood oxygen concentration below reference range (finding)


subject: UMLS:C1831991

subject_name: Carcinoembryonic Antigen-Expressing Measles Virus

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C1831991

object_name: Recurrent Glioblastoma


subject: UMLS:C1831991

object_name: Childhood Anaplastic Oligodendroglioma


subject: UMLS:C1831991

object_name: anaplastic oligodendroglioma


subject: UMLS:C1831991

object_name: Adult Anaplastic Oligodendroglioma


subject: UMLS:C1831991

object_name: Grade III Childhood Astrocytoma


subject: UMLS:C1831991

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C1831991

object_name: anaplastic astrocytoma


subject: UMLS:C1831991

object_name: mixed glioma


subject: UMLS:C1831991

object_name: Adult Mixed Glioma


subject: UMLS:C1831991

object_name: Childhood Mixed Glioma


subject: UMLS:C5420753

subject_name: Gallium Ga 68-NOTA-anti-MMR-VHH2 Nanobody

object_name: atherosclerosis


subject: UMLS:C5420753

object_name: sarcoidosis


subject: UMLS:C5420753

object_name: sarcoidosis, susceptibility to, 1


subject: UMLS:C5420753

object_name: cardiac sarcoidosis


subject: UMLS:C5420753

object_name: hemophagocytic syndrome


subject: UMLS:C5420753

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C5420753

object_name: non-Hodgkin lymphoma


subject: UMLS:C5420753

object_name: carotid stenosis


subject: UMLS:C5420753

object_name: cancer


subject: UMLS:C5420753

object_name: neoplasm


subject: CHEBI:9168

subject_name: Sirolimus

object_name: bladder tumor


subject: CHEBI:9168

object_name: urinary bladder carcinoma


subject: CHEBI:9168

object_name: urinary bladder cancer


subject: CHEBI:9168

object_name: childhood bladder carcinoma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Stage IVB Hepatocellular Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IVA Hepatocellular Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v7


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:44208979

subject_name: Acyline

object_name: Uses contraception (finding)


subject: UMLS:C0668202

subject_name: acyline


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: 1p/19q Codeletion


subject: CHEBI:72564

subject_name: Temozolomide


subject: UMLS:C4082706

subject_name: Temodal

object_name: Anaplastic glioma of brain


subject: UMLS:C4082706


subject: UMLS:C3827152


subject: CHEBI:71940

subject_name: Tadalafil

object_name: sarcopenia


subject: UMLS:C0354604

subject_name: oral anticoagulants

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0354604

object_name: obesity


subject: UMLS:C0354604

object_name: Obesity, CTCAE


subject: UMLS:C0354604

object_name: Adverse effects in the therapeutic use of anticoagulants


subject: UMLS:C0354604

object_name: Poisoning by, adverse effect of and underdosing of anticoagulants


subject: UMLS:C0354604

object_name: Poisoning by anticoagulant


subject: UNII:A9C8MNF7CA

subject_name: Prinaberel

object_name: long QT syndrome


subject: UNII:A9C8MNF7CA

object_name: familial long QT syndrome


subject: UNII:A9C8MNF7CA

object_name: Prolonged QT interval


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: recurrent hypersomnia


subject: CHEBI:30830

object_name: idiopathic hypersomnia


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: neuralgia


subject: CHEBI:46195

object_name: Neuropathic pain


subject: CHEBI:681569

subject_name: Clofarabine

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:681569

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:681569

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:681569

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:681569

object_name: B Acute Lymphoblastic Leukemia, BCR-ABL1-Like


subject: CHEBI:681569

object_name: testicular leukemia


subject: CHEBI:681569

object_name: central nervous system leukemia


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:70839


subject: CHEBI:70839


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:135207

subject_name: Clofedanol

object_name: rectal carcinoma


subject: CHEBI:135207

object_name: rectal cancer


subject: CHEBI:135207

object_name: Childhood Rectal Carcinoma


subject: CHEBI:135207

object_name: colon carcinoma


subject: CHEBI:135207

object_name: colon cancer


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: cancer


subject: CHEBI:68534

object_name: neoplasm


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Community-Acquired Pneumonia


subject: UMLS:C1247687

subject_name: progesterone vaginal suppository

object_name: Premature Labor


subject: UMLS:C0040349

subject_name: Tocolytic Agents


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:41879

object_name: reactive airway disease


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8707

subject_name: Quetiapine

object_name: alcohol dependence


subject: UMLS:C0909027

subject_name: dai-kenchu-to

object_name: Postoperative ileus


subject: CHEBI:50730

subject_name: Montelukast

object_name: coronary artery disorder


subject: CHEBI:132922

object_name: epilepsy


subject: CHEBI:132922

object_name: focal epilepsy


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:7565

subject_name: Nifedipine


subject: CHEBI:7565


subject: UMLS:C1268858

subject_name: Magnesium supplement


subject: UMLS:C1268858

object_name: COPD, severe early onset


subject: UMLS:C1268858

object_name: chronic obstructive pulmonary disease


subject: CHEBI:35110

subject_name: magnesium monohydroxide


subject: CHEBI:35110


subject: CHEBI:35110


subject: CHEBI:35149

subject_name: magnesium hydroxide


subject: CHEBI:35149


subject: CHEBI:35149


subject: CHEBI:6637

subject_name: Nemalite


subject: CHEBI:6637


subject: CHEBI:6637


subject: PUBCHEM.COMPOUND:20473337

subject_name: Diethylcarbamazine

object_name: filarial elephantiasis


subject: PUBCHEM.COMPOUND:72728820

subject_name: Moxidectin


subject: PUBCHEM.COMPOUND:53397745

subject_name: Milbemycin A4


subject: PUBCHEM.COMPOUND:57369871

subject_name: Milbemycin D


subject: UNII:GN429E725A

subject_name: Nedisertib

object_name: neuroendocrine neoplasm


subject: CHEBI:18185

subject_name: gamma-Tocopherol

object_name: coronary microvascular disorder


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Hemorrhagic Shock


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: UMLS:C4683552

object_name: squamous cell carcinoma


subject: UMLS:C4683552

object_name: oral cavity squamous cell carcinoma


subject: UMLS:C4683552

object_name: lymphoid interstitial pneumonia


subject: UMLS:C4683552

object_name: benign neoplasm of lip


subject: UMLS:C4683552

object_name: Neoplasm of uncertain or unknown behavior of larynx


subject: UMLS:C4683552

object_name: laryngeal disorder


subject: UMLS:C4683552

object_name: larynx carcinoma in situ


subject: UMLS:C4683552

object_name: benign laryngeal neoplasm


subject: CHEBI:8499

subject_name: Propranolol

object_name: autism spectrum disorder


subject: PUBCHEM.COMPOUND:72959169

subject_name: Mayzent

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:72959169

object_name: Alzheimer disease


subject: PUBCHEM.COMPOUND:72959169

object_name: mild neurocognitive disorder


subject: UNII:RR6P8L282I

subject_name: Siponimod


subject: UNII:RR6P8L282I


subject: UNII:RR6P8L282I


subject: UMLS:C5238233

subject_name: Wee1 Inhibitor ZN-c3

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: UMLS:C5238233

object_name: Advanced Ovarian Carcinoma


subject: UMLS:C5238233

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C5238233

object_name: Stage III Ovarian Cancer AJCC v8


subject: UMLS:C5238233

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C5238233

object_name: Advanced Fallopian Tube Carcinoma


subject: UMLS:C5238233

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C5238233

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: UMLS:C5238233

object_name: Advanced Primary Peritoneal Carcinoma


subject: UMLS:C5238233

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C5238233

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: UMLS:C0086135

subject_name: DDAVP

object_name: Hemorrhage


subject: CHEBI:95021

subject_name: pemetrexed

object_name: precancerous condition


subject: CHEBI:95021

object_name: myeloproliferative neoplasm


subject: CHEBI:95021

object_name: lymphoproliferative syndrome


subject: CHEBI:95021

object_name: Myelodysplasia


subject: CHEBI:95021

object_name: Myelofibrosis due to another disorder


subject: CHEBI:95021

object_name: leukemia


subject: CHEBI:95021

object_name: childhood leukemia


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:73788

subject_name: Ala-Gln

object_name: Stomach cancer


subject: CHEBI:73788

object_name: gastric cancer


subject: CHEBI:73788

object_name: pancreatic neoplasm


subject: CHEBI:73788

object_name: exocrine pancreatic carcinoma


subject: CHEBI:73788

object_name: malignant pancreatic neoplasm


subject: UMLS:C0594563

subject_name: Dipeptiven


subject: UMLS:C0594563


subject: UMLS:C0594563


subject: UMLS:C0594563


subject: UMLS:C0594563


subject: CHEBI:135012

subject_name: bunitrolol


subject: CHEBI:135012


subject: CHEBI:135012


subject: CHEBI:135012


subject: CHEBI:135012


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: PUBCHEM.COMPOUND:66586232

object_name: dental caries


subject: PUBCHEM.COMPOUND:66586232

object_name: Dental Caries, CTCAE


subject: PUBCHEM.COMPOUND:66586232

object_name: Orthodontic appliance complication


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: CHEBI:3614


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Haemorrhage from placenta praevia, with delivery


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: TRAUMA/INJURY PROBLEM


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C5392674

object_name: Alzheimer disease


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: Acute Stroke


subject: CHEBI:146178

object_name: brain edema


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Non-small cell lung cancer stage I


subject: CHEBI:94366

subject_name: itraconazole

object_name: Well adult


subject: CHEBI:8426

subject_name: Probenecid


subject: CHEBI:15365

subject_name: Aspirin

object_name: pulmonary hypertension


subject: CHEBI:9150

subject_name: Simvastatin


subject: UMLS:C5564711

object_name: Overweight


subject: CHEBI:231693

subject_name: Capmatinib

object_name: cancer


subject: CHEBI:231693

object_name: neoplasm


subject: CHEBI:231693

object_name: lung cancer


subject: CHEBI:231693

object_name: lung neoplasm


subject: CHEBI:231693

object_name: lung carcinoma


subject: CHEBI:231693

object_name: Gene Product Sequence Variation


subject: CHEBI:231693

object_name: Gene Abnormality


subject: CHEBI:18167

subject_name: alpha-maltose

object_name: colon carcinoma


subject: CHEBI:18167

object_name: colorectal cancer


subject: CHEBI:18167

object_name: colon cancer


subject: CHEMBL.COMPOUND:CHEMBL2107951

subject_name: MALTODEXTRIN


subject: CHEMBL.COMPOUND:CHEMBL2107951


subject: CHEMBL.COMPOUND:CHEMBL2107951


subject: CHEBI:17925

subject_name: alpha-D-glucose


subject: CHEBI:17925


subject: CHEBI:17925


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17634

subject_name: D-glucose


subject: CHEBI:17634


subject: CHEBI:17634


subject: CHEBI:17234


subject: CHEBI:17234


subject: CHEBI:17234


subject: CHEBI:167309

subject_name: Methadone

object_name: Opiate Withdrawal Syndrome


subject: CHEBI:15365

object_name: preeclampsia postpartum


subject: UNII:3110E3AO8S

subject_name: Basimglurant

object_name: fragile X syndrome


subject: UMLS:C4045840


subject: MESH:C000727548


subject: MESH:C000727548


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Decreased Immunologic Activity [PE]


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate


subject: CHEBI:17303

subject_name: Morphine


subject: UNII:FW00DG4E3P

subject_name: DONISLECEL

object_name: type 1 diabetes mellitus 1


subject: UNII:FW00DG4E3P

object_name: type 1 diabetes mellitus


subject: CHEBI:231683

subject_name: Anakinra

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:X4D0G881CN

object_name: pulmonary sarcoidosis


subject: CHEBI:36796

subject_name: duloxetine

object_name: traumatic encephalopathy


subject: CHEBI:36796

object_name: traumatic brain injury


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Urinary complication


subject: UNII:6XC1PAD3KF

object_name: Musculoskeletal Complication


subject: UNII:6XC1PAD3KF

object_name: DS Stage II Plasma Cell Myeloma


subject: UNII:6XC1PAD3KF

object_name: DS Stage I Plasma Cell Myeloma


subject: UNII:6XC1PAD3KF

object_name: breast adenocarcinoma


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:3485

subject_name: Cefdinir

object_name: infectious otitis media


subject: CHEBI:3485

object_name: Acute otitis media


subject: UMLS:C0285868

subject_name: Omnicef


subject: UMLS:C0285868


subject: UNII:G6S5600O0D

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C5201230

subject_name: Paclitaxel Liquid Injection

object_name: triple-negative breast carcinoma


subject: UMLS:C5201230

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C3854151

subject_name: Injection, paclitaxel, 1 mg administered


subject: UMLS:C3854151


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UMLS:C3827160

object_name: Metastatic urothelial carcinoma


subject: CHEBI:9907

subject_name: ursodiol

object_name: Huntington disease


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: congestive heart failure


subject: UMLS:C3274916

subject_name: GRASPA

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3274916

object_name: acute myeloid leukemia


subject: CHEBI:63638

subject_name: Vigabatrin

object_name: cocaine dependence


subject: CHEBI:63638

object_name: alcohol abuse


subject: CHEBI:63638

object_name: alcohol dependence


subject: UMLS:C5979854

subject_name: CXC Chemokine Receptor 4 Antagonist [EPC]

object_name: acute lymphoblastic leukemia


subject: UMLS:C5979854


subject: UMLS:C5979854


subject: UNII:6E01CG547T

subject_name: MITOQUINONE MESYLATE

object_name: mild neurocognitive disorder


subject: UNII:6E01CG547T

object_name: mild cognitive impairment


subject: UNII:6E01CG547T

object_name: Frailty


subject: UMLS:C5690695

subject_name: mitoquinone mesylate


subject: UMLS:C5690695


subject: UMLS:C5690695


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Sepsis


subject: UNII:L500PR95QA

object_name: Sepsis, CTCAE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:76842


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: UMLS:C5854352

object_name: hemophilia B


subject: UMLS:C5854352

object_name: hemophilia B leyden


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: outcomes general quality of life


subject: UNII:YZS3R7LP44

object_name: Perceived quality of life


subject: UNII:YZS3R7LP44

object_name: Good quality of life


subject: UNII:YZS3R7LP44

object_name: breast neoplasm


subject: UMLS:C4079746

object_name: primary orthostatic hypotension


subject: UMLS:C4079746

object_name: Neurogenic Orthostatic Hypotension


subject: UMLS:C4079746

object_name: orthostatic hypotension


subject: UMLS:C4079746

object_name: multiple system atrophy


subject: UMLS:C4079746

object_name: Multiple system atrophy (MSA) with orthostatic hypotension


subject: UMLS:C4079746

object_name: pure autonomic failure


subject: UMLS:C4079746

object_name: Parkinson disease


subject: CHEBI:47426

subject_name: Furosemide

object_name: Ovarian torsion


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: heart failure


subject: CHEBI:39548

object_name: congestive heart failure


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: hypertension


subject: UMLS:C0360094

object_name: Hypertension, CTCAE


subject: CHEBI:91594

object_name: esophageal disorder


subject: UMLS:C0678133

subject_name: Taxol


subject: GTOPDB:4934

subject_name: G-CSF


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UMLS:C1100128

object_name: chronic hepatitis B virus infection


subject: UMLS:C1100128

object_name: hepatitis B


subject: CHEBI:64816

object_name: grade 3B follicular lymphoma


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UNII:KG6VO684Z6

subject_name: Polatuzumab vedotin


subject: UMLS:C3641728


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:2Y3T5IF01Z

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:2Y3T5IF01Z

object_name: high grade B-cell lymphoma


subject: UNII:2Y3T5IF01Z


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466